Benzinga's Top Downgrades - Esperion Therapeutics (NASDAQ:ESPR)

Analysts at Needham downgraded Netflix, Inc. NFLX from Buy to Hold. Netflix shares fell 1.38 percent to $95.34 in pre-market trading.
Analysts at Iberia Capital downgraded Rowan Companies PLC RDC from Outperform to Sector Perform. Rowan shares climbed 7.59 percent to close at $19.00 on Friday.
Cowen & Company downgraded LogMeIn Inc LOGM from Outperform to Market Perform. LogMeIn shares fell 0.49 percent to close at $63.12 on Friday.
Analysts at Morgan Stanley downgraded Fifth Third Bancorp FITB from Overweight to Equalweight. Fifth Third Bancorp shares declined 0.91 percent to close at $17.43 on Friday.
Wallachbeth downgraded Esperion Therapeutics Inc ESPR to Hold. Esperion Therapeutics shares declined 2.42 percent to $10.10 in pre-market trading.
Barclays downgraded Ellie Mae Inc ELLI from Overweight to Equalweight. Ellie Mae shares rose 1.37 percent to close at $92.91 on Friday.
Pacific Crest downgraded Skyworks Solutions Inc SWKS from Overweight to Sector Weight. Skyworks Solutions shares dropped 2.56 percent to $61.00 in pre-market trading.
Argus Research downgraded Hershey Co HSY from Buy to Hold. Hershey shares fell 0.18 percent to $111.75 in pre-market trading.
Analysts at Morgan Stanley downgraded Illumina, Inc. ILMN from Equalweight to Underweight. The price target for Illumina has been lowered from $130 to $110. Illumina shares fell 4.07 percent to $135.00 in pre-market trading.
UBS downgraded LATAM Airlines Group SA (ADR) LFL to Sell. LATAM Airlines shares gained 2.88 percent to close at $6.79 on Friday.

Market News and Data brought to you by Benzinga APIs